ArQule Inc
AstraZeneca Plc
Laekna Therapeutics Shanghai Co Ltd
Merck & Co Inc
Merck KGaA
Novartis AG
Prous Institute for Biomedical Research SA
Published | Pages | Publisher | Report code |
---|---|---|---|
Dec 2019 | 69 | Global Markets Direct | ASDR-504371 |
ArQule Inc
AstraZeneca Plc
Laekna Therapeutics Shanghai Co Ltd
Merck & Co Inc
Merck KGaA
Novartis AG
Prous Institute for Biomedical Research SA